Preclinical
|
CD19 (CD19 Molecule) • KMT2A (Lysine Methyltransferase 2A) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • PRAME (Preferentially Expressed Antigen In Melanoma) • CDK9 (Cyclin Dependent Kinase 9) • IGLL5 (Immunoglobulin Lambda Like Polypeptide 5)
|
KMT2A rearrangement • MLL rearrangement • MLL rearrangement
|
Venclexta (venetoclax) • Imbruvica (ibrutinib) • Rituxan (rituximab) • doxorubicin hydrochloride • PRT2527